Shu Y - Search Results

1

[Effect of recombinant adenovirus-p53 on growth and chemosensitivity of human lung adenocarcinoma cell lines].

Wang Z, Lu B, Wang T, De W, Shu Y. Wang Z, et al. Among authors: shu y. Zhongguo Fei Ai Za Zhi. 2006 Apr 20;9(2):127-31. doi: 10.3779/j.issn.1009-3419.2006.02.06. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21144296 Free article. Chinese.

2

[Effect of adenomatous polyposis coli(APC) promoter methylation on gene transcription in lung cancer cell lines].

Zhang LX, Pan SY, Chen D, Xie EF, Gao L, Shu YQ, Lu ZH, Cheng L, Yang D, Zhang JN. Zhang LX, et al. Ai Zheng. 2007 Jun;26(6):576-80. Ai Zheng. 2007. PMID: 17562260 Free article. Chinese.

3

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.

Zhu W, Shan X, Wang T, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Int J Cancer. 2010 Dec 1;127(11):2520-9. doi: 10.1002/ijc.25260. Int J Cancer. 2010. PMID: 20162574

4

[microRNA expression profiling of side population cells in human lung cancer and preliminary analysis].

Xu X, Lu X, Sun J, Shu Y. Xu X, et al. Among authors: shu y. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):665-9. doi: 10.3779/j.issn.1009-3419.2010.07.02. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673480 Free PMC article. Chinese.

5

[Current status and prospects of maintenance therapy in advanced stage non-small cell lung cancer].

Quan L, Chen W, Shu Y. Quan L, et al. Among authors: shu y. Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):637-41. doi: 10.3779/j.issn.1009-3419.2010.06.013. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20681454 Free PMC article. Review. Chinese. No abstract available.

6

[Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer.].

Wang T, Sun J, Gao W, Shen H, Li X, Yin Y, Shu Y, Guo R. Wang T, et al. Among authors: shu y. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1287-90. doi: 10.3779/j.issn.1009-3419.2009.12.12. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723385 Free article. Chinese.

7

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer.

Yin YM, Geng YT, Shao YF, Hu XL, Li W, Shu YQ, Wang ZX. Yin YM, et al. J Exp Clin Cancer Res. 2010 Sep 15;29(1):126. doi: 10.1186/1756-9966-29-126. J Exp Clin Cancer Res. 2010. PMID: 20843324 Free PMC article.

8

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.

Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, Shu YQ. Wei J, et al. Chin J Cancer. 2011 Jun;30(6):407-14. doi: 10.5732/cjc.010.10522. Chin J Cancer. 2011. PMID: 21627863 Free PMC article.

9

Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC.

Han L, Kong R, Yin DD, Zhang EB, Xu TP, De W, Shu YQ. Han L, et al. Med Oncol. 2013 Dec;30(4):694. doi: 10.1007/s12032-013-0694-5. Epub 2013 Aug 24. Med Oncol. 2013. PMID: 23979857

10

Enhanced charge transfer by gold nanoparticle at DNA modified electrode and its application to label-free DNA detection.

Yang Y, Li C, Yin L, Liu M, Wang Z, Shu Y, Li G. Yang Y, et al. Among authors: shu y. ACS Appl Mater Interfaces. 2014 May 28;6(10):7579-84. doi: 10.1021/am500912m. Epub 2014 Apr 23. ACS Appl Mater Interfaces. 2014. PMID: 24734899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,854 results

Search Page

Filters